HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Kraft, S. C. Articles by Ford, H. E. Search for Related Content PubMed Articles by Kraft, S. C. Articles by Ford, H. E.

The Effects of Single Low Antigen Doses on Immunologic Responsiveness in Adult Rabbits¹

From the Departments of Medicine and Pediatrics, University of Chicago, Chicago, Illinois

Abstract

1. The effects of single low doses of bovine serum albumin (BSA) on immune responsiveness were studied by administering 0.1 or 1.0 mg of BSA intravenously (i.v.) to adult rabbits. Anti-BSA was detected in 50% of each group. The injection of 1.0 mg of BSA inhibited the antibody responses to challenging doses of 100 mg i.v. of BSA given 21 and 42 days later. This hyporesponsiveness was not due to the presence of circulating antigen. Following the first 100 mg BSA challenge, a transient decrease in the strength of the antibody-antigen bonds was observed.

2. Rabbits receiving a 10-fold lower preliminary BSA dose did not exhibit immune suppression or a decrease in the strength of antibody-antigen bonds. The immunocompetent cells of these animals were affected by the 0.1-mg i.v. BSA injection, however, as demonstrated by slightly more antibody following the second 100-mg BSA challenge, a more rapid onset of immune elimination, and a higher mean effect of dilution following the second challenge.

3. Since immunosuppression has not been observed using 10-fold lower or higher BSA doses, there appears to be something unique about a single 1.0-mg BSA injection. Although the cellular mechanisms involved remain unclear, 1.0 mg i.v. of BSA more efficiently suppressed the population of immunologically competent cells that form antibodies capable of stronger antigen binding.

Footnotes

This study was supported by United States Public Health Service Research Grants AM-10473 and AI-07854. Presented in part at a meeting of the Federation of American Societies for Experimental Biology, Atlantic City, New Jersey, April 1968 (Fed. Proc., 27: 473, 1968).

² Recipient of United States Public Health Service Research Career Development Award 1-K3-AI-13, 936.

³ Recipient of United States Public Health Service Research Career Development Award 1-K4-AI-38,899.